Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1466 (Bishydroxycoumarin, Dicoumarol, Dicoumarolum, Dicumarol, NSC-17860, NSC-221570, NSC-41834) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
aldo-keto reductase family 1 member B/Aldose reductase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2622] [GtoPdb: 2768] [UniProtKB: P07943] | ||||||||
ChEMBL | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | B | 5.39 | pIC50 | 4093 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ATP phosphoribosyltransferase in Mycobacterium tuberculosis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6086] [UniProtKB: P9WMN1] | ||||||||
ChEMBL | Inhibition of Mycobacterium tuberculosis HisG assessed as phosphoribosyl ATP production by spectrophotometry | B | 4.22 | pKi | 60000 | nM | Ki | J Med Chem (2008) 51: 5984-5992 [PMID:18778048] |
CYP2C9/Cytochrome P450 2C9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3397] [GtoPdb: 1326] [UniProtKB: P11712] | ||||||||
ChEMBL | DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 6.52 | pIC50 | 300 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Enoyl-[acyl-carrier-protein] reductase [NADH] in Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2150835] [UniProtKB: Q5NGQ3] | ||||||||
ChEMBL | Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay | B | 4.33 | pIC50 | 47000 | nM | IC50 | J Med Chem (2013) 56: 5275-5287 [PMID:23815100] |
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97] | ||||||||
ChEMBL | Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis | B | 7.41 | pKi | 39 | nM | Ki | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay | B | 5.01 | pEC50 | 9780 | nM | EC50 | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay | B | 5.89 | pEC50 | 1300 | nM | EC50 | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay | B | 5.89 | pEC50 | 1300 | nM | EC50 | J Med Chem (2017) 60: 362-372 [PMID:27976894] |
Human immunodeficiency virus type 1 integrase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3471] [UniProtKB: Q7ZJM1] | ||||||||
ChEMBL | Inhibitory activity against 3'-processing of DNA by HIV-1 integrase | F | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (1997) 40: 242-249 [PMID:9003523] |
ChEMBL | Integration of DNA by HIV -1 integrase | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (1997) 40: 242-249 [PMID:9003523] |
mitogen-activated protein kinase 1/MAP kinase ERK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4040] [GtoPdb: 1495] [UniProtKB: P28482] | ||||||||
ChEMBL | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) | B | 5.35 | pIC50 | 4426 | nM | IC50 | DrugMatrix in vitro pharmacology data |
NAD(P)H dehydrogenase [quinone] 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3091269] [UniProtKB: P05982] | ||||||||
ChEMBL | Competitive binding affinity to rat liver NQO1 in presence of NADPH | B | 9 | pKi | 1 | nM | Ki | J Med Chem (2018) 61: 6983-7003 [PMID:29712428] |
Quinone reductase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3623] [UniProtKB: P15559] | ||||||||
ChEMBL | Inhibition of human recombinant NQO1 | B | 6.35 | pIC50 | 450 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 6246-6254 [PMID:17011189] |
ChEMBL | Inhibition of human recombinant NQO1 in presence of BSA | B | 6.35 | pIC50 | 450 | nM | IC50 | J Med Chem (2007) 50: 6316-6325 [PMID:17999461] |
ChEMBL | Inhibition of human recombinant NQO1 in presence of BSA | B | 6.39 | pIC50 | 404 | nM | IC50 | J Med Chem (2009) 52: 7142-7156 [PMID:19877692] |
ChEMBL | Inhibition of recombinant human NQO1 assessed as reduction in oxidation of NADPH to NADP+ using b-lap as substrate and NADPH in presence of 0.14% (w/v) BSA | B | 6.46 | pIC50 | 350 | nM | IC50 | Eur J Med Chem (2017) 127: 828-839 [PMID:27829520] |
ChEMBL | Inhibition of human recombinant NQO1 | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2007) 50: 6316-6325 [PMID:17999461] |
ChEMBL | Inhibition of human recombinant NQO1 | B | 8.59 | pIC50 | 2.6 | nM | IC50 | J Med Chem (2009) 52: 7142-7156 [PMID:19877692] |
proprotein convertase subtilisin/kexin type 7/Subtilisin/kexin type 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2232] [GtoPdb: 2387] [UniProtKB: Q16549] | ||||||||
ChEMBL | Inhibition of recombinant type 8 subtilisin using Arg-Glu-(EDANS)- Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys-(DALBCYL)-Arg fluorogenic substrate preincubated for 1 hr measured after 1 hr at 1 min interval by fluorescence assay | B | 5.89 | pIC50 | 1300 | nM | IC50 | J Nat Prod (2011) 74: 1353-1357 [PMID:21510613] |
Urease in Canavalia ensiformis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4161] [UniProtKB: P07374] | ||||||||
ChEMBL | Inhibition of jack bean urease | B | 4.82 | pIC50 | 15135.61 | nM | IC50 | Bioorg Med Chem (2008) 16: 3456-3461 [PMID:18280742] |
ChEMBL | Inhibition of jack bean urease | B | 4.82 | pIC50 | 15010 | nM | IC50 | Eur J Med Chem (2022) 234: 114273-114273 [PMID:35305460] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]